Literature DB >> 12089364

Identification of functions of peroxisome proliferator-activated receptor alpha in proximal tubules.

Yuji Kamijo1, Kazuhiko Hora, Naoki Tanaka, Nobuteru Usuda, Kendo Kiyosawa, Tamie Nakajima, Frank J Gonzalez, Toshifumi Aoyama.   

Abstract

Peroxisome proliferator-activated receptor alpha(PPARalpha) is a member of the steroid/nuclear receptor superfamily that is intensively expressed in the kidney, but its physiologic function is unknown. In this study, PPARalpha-null mice were used to help clarify the function. Starved PPARalpha-null mice were found to secrete significantly more quantities of urine albumin than starved wild-type mice. Furthermore, the appearance of giant lysosomes, marked accumulation of albumin, and an impaired ability concerning albumin digestion were found only in proximal tubules of the starved PPARalpha-null mice. These abnormalities were probably derived from ATP insufficiency as a result of the starvation-induced decline of carbohydrate metabolism and a lack of PPARalpha-dependent fatty acid metabolism. It is interesting that these abnormalities disappeared when glucose was administered. Taken together, these findings demonstrate important functions of PPARalpha in the proximal tubules, the dynamic regulation of the protein-degradation system through maintenance of ATP homeostasis, and emphasize the importance of the fatty acid metabolism in renal physiology.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12089364     DOI: 10.1097/01.asn.0000018403.61042.56

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  16 in total

1.  Peroxisome proliferator-activated receptor α-dependent renoprotection of murine kidney by irbesartan.

Authors:  Makoto Harada; Yuji Kamijo; Takero Nakajima; Koji Hashimoto; Yosuke Yamada; Hisashi Shimojo; Frank J Gonzalez; Toshifumi Aoyama
Journal:  Clin Sci (Lond)       Date:  2016-08-05       Impact factor: 6.124

Review 2.  PPARalpha: an emerging therapeutic target in diabetic microvascular damage.

Authors:  Anne Hiukka; Marianna Maranghi; Niina Matikainen; Marja-Riitta Taskinen
Journal:  Nat Rev Endocrinol       Date:  2010-06-22       Impact factor: 43.330

3.  Peroxisome proliferator-activated receptor α mediates enhancement of gene expression of cerebroside sulfotransferase in several murine organs.

Authors:  Takero Nakajima; Yuji Kamijo; Huang Yuzhe; Takefumi Kimura; Naoki Tanaka; Eiko Sugiyama; Kozo Nakamura; Mamoru Kyogashima; Atsushi Hara; Toshifumi Aoyama
Journal:  Glycoconj J       Date:  2012-10-13       Impact factor: 2.916

4.  Fenofibrate, a PPARα agonist, protect proximal tubular cells from albumin-bound fatty acids induced apoptosis via the activation of NF-kB.

Authors:  Nan Zuo; Xiaoyu Zheng; Hanzhe Liu; Xiaoli Ma
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

5.  Transgenic expression of proximal tubule peroxisome proliferator-activated receptor-alpha in mice confers protection during acute kidney injury.

Authors:  Shenyang Li; Kiran K Nagothu; Varsha Desai; Taewon Lee; William Branham; Carrie Moland; Judit K Megyesi; Mark D Crew; Didier Portilla
Journal:  Kidney Int       Date:  2009-08-26       Impact factor: 10.612

6.  Molecular mechanism of age-specific hepatic lipid accumulation in PPARalpha (+/-):LDLR (+/-) mice, an obese mouse model.

Authors:  Yufeng Li; Eiko Sugiyama; Shin Yokoyama; Lingling Jiang; Naoki Tanaka; Toshifumi Aoyama
Journal:  Lipids       Date:  2008-03-12       Impact factor: 1.880

7.  Age-dependent PPARα activation induces hepatic sulfatide accumulation in transgenic mice carrying the hepatitis C virus core gene.

Authors:  Yangyang Tian; Yang Yang; Xiaowei Zhang; Takero Nakajima; Naoki Tanaka; Eiko Sugiyama; Yuji Kamijo; Yu Lu; Kyoji Moriya; Kazuhiko Koike; Frank J Gonzalez; Toshifumi Aoyama
Journal:  Glycoconj J       Date:  2016-06-18       Impact factor: 2.916

8.  PPARα Activation Protects against Anti-Thy1 Nephritis by Suppressing Glomerular NF-κB Signaling.

Authors:  Koji Hashimoto; Yuji Kamijo; Takero Nakajima; Makoto Harada; Makoto Higuchi; Takashi Ehara; Hidekazu Shigematsu; Toshifumi Aoyama
Journal:  PPAR Res       Date:  2012-05-16       Impact factor: 4.964

9.  Peroxisome proliferator-activated receptors in diabetic nephropathy.

Authors:  Shinji Kume; Takashi Uzu; Keiji Isshiki; Daisuke Koya
Journal:  PPAR Res       Date:  2009-03-04       Impact factor: 4.964

10.  Pemafibrate Protects against Fatty Acid-Induced Nephropathy by Maintaining Renal Fatty Acid Metabolism.

Authors:  Daiki Aomura; Makoto Harada; Yosuke Yamada; Takero Nakajima; Koji Hashimoto; Naoki Tanaka; Yuji Kamijo
Journal:  Metabolites       Date:  2021-06-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.